SIGNATUREFD, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 124 filers reported holding G1 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$64,061
-42.2%
44,4870.0%0.00%
-33.3%
Q2 2023$110,773
-7.1%
44,4870.0%0.00%0.0%
Q1 2023$119,225
-50.7%
44,487
-0.1%
0.00%
-57.1%
Q4 2022$241,917
-56.6%
44,552
-0.2%
0.01%
-63.2%
Q3 2022$558,000
+153.6%
44,657
+0.4%
0.02%
+171.4%
Q2 2022$220,000
-10.9%
44,487
+36.9%
0.01%0.0%
Q1 2022$247,000
-25.6%
32,4870.0%0.01%
-30.0%
Q4 2021$332,000
-23.9%
32,4870.0%0.01%
-33.3%
Q3 2021$436,000
-38.8%
32,4870.0%0.02%
-46.4%
Q2 2021$713,000
+41.5%
32,487
+55.1%
0.03%
+27.3%
Q1 2021$504,000
+33.7%
20,9420.0%0.02%
+22.2%
Q4 2020$377,000
+10.9%
20,942
-28.9%
0.02%0.0%
Q3 2020$340,000
-52.4%
29,4420.0%0.02%
-58.1%
Q2 2020$714,000
+120.4%
29,4420.0%0.04%
+53.6%
Q1 2020$324,000
-41.4%
29,442
+40.6%
0.03%
-31.7%
Q4 2019$553,000
-36.0%
20,942
-44.8%
0.04%
-42.3%
Q3 2019$864,000
-25.7%
37,9420.0%0.07%
-29.7%
Q2 2019$1,163,000
+84.6%
37,9420.0%0.10%
+87.0%
Q1 2019$630,000
-13.3%
37,9420.0%0.05%
-20.6%
Q4 2018$727,000
-33.6%
37,942
+81.2%
0.07%
-38.7%
Q3 2018$1,095,000
+66.2%
20,942
+38.1%
0.11%
+50.0%
Q2 2018$659,00015,1620.07%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders